NCT00801814View on ClinicalTrials.gov

Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

August 31, 2006

Conditions
Blood Glucose, Postprandial
Interventions
DIETARY_SUPPLEMENT

PolyGlycopleX (PGX)

2.5 grams of PGX

DIETARY_SUPPLEMENT

PolyGlycopleX (PG)

5.0 grams of PGX

DIETARY_SUPPLEMENT

PolyGlycopleX

7.5 grams of PGX

DIETARY_SUPPLEMENT

Control

0g of PGX

DIETARY_SUPPLEMENT

Second Control

0g of PGX

Trial Locations (1)

M5C 2X3

Glycemic Index Laboratories, Inc., Toronto

Sponsors
All Listed Sponsors
collaborator

InovoBiologic Inc.

INDUSTRY

collaborator

Canadian Center for Functional Medicine

OTHER

lead

Glycemic Index Laboratories, Inc

INDUSTRY

NCT00801814 - Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia | Biotech Hunter | Biotech Hunter